Latest News and Press Releases

MELBOURNE, AUSTRALIA--(Marketwired - Apr 4, 2013) - IDT Australia Ltd (ASX: IDT) is pleased to announce the appointment of Dr. Paul MacLeman as Chief Executive Officer of the Company, effective...

SAN DIEGO, CA--(Marketwire - Mar 25, 2013) - Vital Therapies, Inc., a development stage biotechnology company focused on developing the first bio-artificial liver for life-threatening acute liver...

BRISBANE, AUSTRALIA--(Marketwire - Mar 22, 2013) - Australian drug discovery and development company Alchemia Limited (ASX: ACL) has appointed two additional non-executive directors (NEDs) to its...

MELBOURNE, AUSTRALIA--(Marketwire - Mar 15, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that the United States Patent and Trademark Office ("USPTO") has...

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Mar 13, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced that Jon W. Salveson has been appointed to the Company's Board of...

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Mar 11, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced financial results for the fourth quarter and year ended December...

BRISBANE, AUSTRALIA--(Marketwire - Mar 6, 2013) - Brisbane based drug discovery and development company Alchemia Limited (ASX: ACL) has been granted a key US patent critical to its platform...

TOKYO--(Marketwire - Mar 6, 2013) - SymBio Pharmaceuticals Limited (JASDAQ: 4582) announced the completion of patient enrollment of its Phase II clinical trial of TREAKISYM® (bendamustine...

BRISBANE, AUSTRALIA--(Marketwire - Feb 28, 2013) - 415 patients recruited; recruitment now closed Participation in sub-study outperformed expectations ...

EDEN PRAIRIE, MN and SYDNEY, AUSTRALIA--(Marketwire - Feb 26, 2013) - Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced that the company is scheduled to attend the following upcoming...